new_0222_0490|FBRX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0490|FBRX|1|Forte Biosciences Inc Total Current Assets (Quarterly) (USD)|Forte Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Forte Biosciences Inc Inventories (Quarterly) (USD)|Forte Biosciences Inc Net PP&E (Quarterly) (USD)|Forte Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Forte Biosciences Inc Total Liabilities (Quarterly) (USD)|Forte Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Forte Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Forte Biosciences Inc Total Deposits (Quarterly) (USD)|Forte Biosciences Inc Book Value (Quarterly) (USD)|Forte Biosciences Inc Retained Earnings (Quarterly) (USD)|Forte Biosciences Inc Treasury Stock (Quarterly) (USD)|Forte Biosciences Inc EV to Revenues|Forte Biosciences Inc EV to Earnings|Forte Biosciences Inc EV to Free Cash Flow|Forte Biosciences Inc EV to Assets (Quarterly)|Forte Biosciences Inc PS Ratio|Forte Biosciences Inc PE Ratio|Forte Biosciences Inc Price to Book Value|Forte Biosciences Inc PEG Ratio|Forte Biosciences Inc Debt to Equity Ratio|Forte Biosciences Inc Dividend Yield|Forte Biosciences Inc Shareholder Yield (TTM)|Forte Biosciences Inc Percent of Shares Outstanding Short|Forte Biosciences Inc Total Receivables (Quarterly) (USD)|Forte Biosciences Inc Total Payables (Quarterly) (USD)|Forte Biosciences Inc Total Capital Stock (Quarterly) (USD)|Forte Biosciences Inc Return on Invested Capital|Forte Biosciences Inc Quality Ratio Score|Forte Biosciences Inc Momentum Score|Forte Biosciences Inc Beta (1Y)|Forte Biosciences Inc Sustainable Growth Rate (TTM)|Forte Biosciences Inc Institutional Investor Ownership Percentage|Forte Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Forte Biosciences Inc Total Employees (Annual)|Forte Biosciences Inc EPS Diluted (Quarterly) (USD)|Forte Biosciences Inc SG&A Expense (Quarterly) (USD)|Forte Biosciences Inc Shares Outstanding|Forte Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Forte Biosciences Inc Ordinary Shares Number (Quarterly)|Forte Biosciences Inc Payout Ratio|Forte Biosciences Inc Quick Ratio (Quarterly)|Forte Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Forte Biosciences Inc Stock Buybacks (Quarterly) (USD)|Forte Biosciences Inc Effective Tax Rate (TTM)|Forte Biosciences Inc Return on Equity|Forte Biosciences Inc Net Income (TTM) (USD)|Forte Biosciences Inc Revenue (TTM) (USD)|Forte Biosciences Inc Dividend Per Share (Quarterly) (USD)|Forte Biosciences Inc Revenue (Quarterly) (USD)|Forte Biosciences Inc Gross Profit (Quarterly) (USD)|Forte Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Forte Biosciences Inc Net Income (Quarterly) (USD)|Forte Biosciences Inc Net Interest Income (Quarterly) (USD)|Forte Biosciences Inc Price (USD)|Forte Biosciences Inc Total Return Price (USD)|Forte Biosciences Inc Enterprise Value (USD)|Forte Biosciences Inc 30-Day Average Daily Volume|Forte Biosciences Inc 1 Year Price Returns (Daily)|Forte Biosciences Inc Short Interest|Forte Biosciences Inc PE Ratio (Forward)|Forte Biosciences Inc PE Ratio (Forward 1y)|Forte Biosciences Inc PS Ratio (Forward)|Forte Biosciences Inc PS Ratio (Forward 1y)|Forte Biosciences Inc Quarterly EPS Estimates (USD)|Forte Biosciences Inc Quarterly Revenue Estimates (USD)|Forte Biosciences Inc Quarterly EPS Surprise|Forte Biosciences Inc Quarterly Revenue Surprise|Forte Biosciences Inc Quarterly Actual EPS (USD)|Forte Biosciences Inc Quarterly Actual Revenue (USD)|Forte Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Forte Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Forte Biosciences Inc Price Target (USD)|Forte Biosciences Inc Consensus Recommendation|Forte Biosciences Inc Price Target Num Estimates|Forte Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Forte Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Forte Biosciences Inc Research and Development Expense (Quarterly) (USD)|Forte Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Forte Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Forte Biosciences Inc Land and Improvements (Quarterly) (USD)|Forte Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Forte Biosciences Inc Other Properties (Quarterly) (USD)|Forte Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0490|FBRX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0490|FBRX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0490|FBRX|5|91.4|91.4||91.4||91.4|91.4|91.4||91.4|91.4||||1.44755244755||||1.44444444444|||1.44339622642||15.2631578947||91.4|91.4|||30.6666666667|30.7142857143||30.5|102.875|181|102.875|102.875|36.1428571429||91.4|||102.875|91.4|||91.4|||||102.875|102.875||1.44339622642|1.44339622642|1.44444444444|1.44303797468|1.43604651163|15.2631578947|||||91.4|91.4|91.4||91.4|91.4|40.1538461538|47.4545454545|26.1|15.8181818182|26.1|32.625|32.625|102.875|104.428571429|||||||
new_0222_0490|FBRX|6|5|5||5||5|5|5||5|5||||286||||414|||424||38||5|5|||6|7||14|8|1|8|8|14||5|||8|5|||5|||||8|8||424|424|414|395|172|38|||||10|10|5||5|5|13|11|20|33|20|16|16|8|7|||||||
new_0222_0490|FBRX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0490|FBRX|201906||||||||||||||||||||||||||||||||||10.7996||-0.0583|0.319||||||-0.0583|||||||||-0.63|-0.63|||||||||||||||||||||||||0.31||||||||
new_0222_0490|FBRX|201909||||||||||||||||||||||||||||||||||10.7996||-0.0639|0.331||||||-0.0639|||||||||-0.69|-0.69|||||||||||||||||||||||||0.353||||||||
new_0222_0490|FBRX|202003||||||||||||||||||||||||||||||||||10.7996||-0.1898|0.673||||||-0.1898|||||||||-2.05|-2.05|||||||||||||||||||||||||1.354|0.013|||||||
new_0222_0490|FBRX|202006|28.144|27.749||0.124||3.433|3.433|||24.878|-41.781||||||||6.5629|||||0.6676||2.567|0.011|||||||3.6504||-9.52|0.76|11.1983||11.1983|||-0.7383|-24.016|||-38.131|||||-34.761|-34.761||14.58|14.58|135.5222|63596.6333||74758|||||-0.18||-311.5||-0.7407||||60|1|1|-0.98|-1.47|1.937|0.014||||||18.85|31.25
new_0222_0490|FBRX|202009|21.617|20.175||0.11||2.411|2.411|||20.319|-46.881||||||||26.7787|||||2.1815||1.556|0.011||||||87.3193|11.2091||-0.45|1.32|11.2166||11.2166|||-0.45||||-42.601|||||-5.1|-5.1||48.51|48.51|523.9423|106348.5667||244686|||||-0.305||-47.541||-0.45||||85|1|4|-8.1067|-2.1367|3.688|0.013||||||38.16|35.13
new_0222_0490|FBRX|202012|59.898|58.765||0.097||2.259|2.259|||58.98|-51.457||||-22.1678||||7.9207|||||2.7403||1.24|0.013||||||97.9352|12.8306|9|-0.3566|1.468|12.8306||12.8306|||-0.3566|-42.683|||-46.487|||||-4.576|-4.576||36.41|36.41|408.3971|69329.5667||351592|||||-0.5933||275.2819||1.04||||88.25|1|4|||3.025|0.014||||||33.86|28.49
new_0222_0490|FBRX|202103|55.872|54.762||0.083||2.37|2.37|||54.698|-56.261||||-20.8436||||8.4655|||||4.5113||1.206|0.013||||||95.6411|13.2529||-0.36|1.419|13.5117||13.5117|||-0.36||||-49.241|||||-4.804|-4.804||34.27|34.27|408.284|279609.5667||609549|||||-0.4912||26.7071||-0.36||||88.6|1|5|-2.4122|-3.0197|3.322|0.014||||||36.19|35.54
new_0222_0490|FBRX|202106|51.881|50.795||0.07||2.978|2.978|||49.909|-62.073||||-21.6578||||9.484|||||9.0237||0.985|0.014|||8|0.6236|||13.6032|10|-0.43|2.224|14.0791||14.0791|||-0.43||||-20.292|||||-5.812|-5.812||33.62|33.62|422.5443|192170.9|130.5898|1270449|||||-0.4367||1.5275||-0.43||||88.2|1|5|-1.5|-2.7|3.523|0.013||||||29.96|29.42
new_0222_0490|FBRX|202109|46.556|45.665||||3.74|3.74|||43.65|-69.824||||0.1179||||1.0005|||||9.8675||2.33|0.015|||3|4.1675||52.0536|14.2412||-0.54|2.043|14.7544||14.7544|||-0.54||||-22.943|||||-7.751|-7.751||2.96|2.96|-1.992|4166389.3333|-93.8982|1455891|||||-0.3725||-44.9664||-0.54||||3.25|3|2|-1.435|-0.7533|5.656|0.009||||||2.71|2.66
new_0222_0490|FBRX|202112|||||||||||||||0.8338||||0.7234|||||6.1222||||||1|5.4232||48.73||||||||||||||||||||||2.14|2.14|-14.0902|490967.8|-94.1225|903297|||||-0.34||||||||||||||||||||1.69|1.33
new_0222_0490|FBRX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.2|||||||||||||||||||||
new_0222_0490|FBRX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.19|||||||||||||||||||||
new_0222_0490|FBRX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.19|||||||||||||||||||||
new_0222_0490|FBRX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.19|||||||||||||||||||||